Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Screenshot20220427at00.10.31.png

 - The Oxford AstraZeneca vaccine (and many other vaccines) take advantage of gene therapy technology too. 

- This chimpanzee adenoviral vector delivers a gene encoding for a coronavirus coat protein (SARS-CoV-2 Spike) to be expressed for a very short time.

- By introducing this coat protein as a target to immune cells, the vaccine facilitates them to recognise and fight a future coronavirus infection!

 

 

 

 

Find out more about the Oxford Astrazeneca vaccine

Find out more about the work of the Gill Hyde Gene Medicine research group at the University of Oxford.